ArticleFrontiers in endocrinology2026
Machine learning model based on routine blood and biochemical parameters for early diagnosis of diabetic kidney disease.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Data-Driven Multidimensional Clinical Phenotypes and Longitudinal Changes in Type 2 Diabetes Mellitus: A Retrospective Cohort Study.Biomedicines · 2026Article
- Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.Frontiers in endocrinology · 2026Article
- Progression of early diagnostic markers for diabetic kidney disease: From single-indicator detection to multi-omics integration modeling.Current research in physiology · 2026Review
- Developing and validating a clinlabomics-based machine-learning model for early detection of occult diabetic kidney disease: implications for primary care screening.Frontiers in endocrinology · 2026Article
- From explainability to clinical actionability: translating artificial intelligence models into decision support for endocrine disease management.Frontiers in endocrinology · 2026Review
- Explainable Artificial Intelligence for Early Diabetic Kidney Disease Risk Profiling in Type 2 Diabetes: Translational Readiness and Clinical Boundaries.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease globally, yet early diagnosis remains challenging due to conventional biomarker limitations, including UACR variability and reduced eGFR sensitivity. While machine learning shows promise in diabetes prediction, its application to early DKD identification using routine parameters remains underexplored. This study aimed to develop and validate machine learning models incorporating routine blood and biochemical parameters for early DKD prediction. Methods: This retrospective study analyzed 3,114 diabetic patients from the Second Affiliated Hospital of Wannan Medical College (EDN1) and 1,496 patients from NHANES 2005-2018 (EDN2) for external validation. Early DKD was defined as UACR 30-300 mg/g with eGFR ≥60 ml/min/1.73m². Seven machine learning algorithms were compared. Feature importance was assessed using SHAP framework, and Mendelian randomization explored causal relationships. Results: Among 3,114 patients, 1,333 (42.8%) had early DKD. Logistic regression achieved optimal performance (AUC = 0.689, sensitivity=40.5%, specificity=81.3%). Top predictors included triglyceride-glucose index (TyG), gender, creatinine, globulin, and age. External validation confirmed significant associations for HbA1c, globulin, TyG, and neutrophil-to-albumin ratio. Conclusions: The machine learning model successfully identified early DKD using routine parameters, with TyG index, HbA1c, and globulin as key predictors, demonstrating potential as a cost-effective screening tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.